SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 24.90-2.1%Nov 19 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (3792)6/30/1998 8:15:00 AM
From: Mazman  Read Replies (2) of 9523
 
Anthony and thread,

Today's Investor's Business Daily (6-30-98) lists Pfizer as one of 20 stocks poised for breakout. Here is relevant text on PFE...

"Sitting at the top of IBD's list in terms of price is Pfizer, which is selling near 109. The stock has an 80 EPS (earnings per share) rank and 93 RS (relative strength). It ran up from 61 a year ago. So it has excellent upside momentum. Earnings this year should rise 23%, surpassing the 17% raise rate of growth the past five years.

"Pfizer is benefiting from strong sales of a hot new drug called Viagra, which is used to treat impotence. The stock has a good institutional following and is part of a strong industry group: drug makers.

"The breakout price is found by looking at the most recent areas of price resistance. In Pfizer's case, it's 115.

"The stock peaked at 121 3/4 on April 21. When it slipped back, it formed a basing pattern that showed resistance at 115 on May 1, May 20, June 19 and June 10.."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext